Repros Therapeutics Inc. Announces the Closing of Public Offering of Common Stock

Published: Jun 26, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

THE WOODLANDS, Texas, June 25, 2013 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced that it has closed an underwritten public offering of 4,312,500 shares of its common stock at a public offering price of $19.00 per share, for net proceeds of approximately $76.5 million after deducting underwriting discounts and other estimated offering expenses.

Help employers find you! Check out all the jobs and post your resume.

Back to news